Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in A Real-World Setting Curtails The Cost of Biologics Without Reducing Efficacy in Psoriasis

media

posted on 2020-10-08, 08:43 authored by Jerry Bagel, Elise Nelson, James Zapata, Alexa Hetzel

<p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.</p>

History

Related Materials

1.
URL - References https://link.springer.com/article/10.1007/s13555-020-00454-z
2.
DOI - Is supplement to Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in A Real-World Setting Curtails The Cost of Biologics Without Reducing Efficacy in Psoriasis

Usage metrics

Dermatology and Therapy

Categories

Keywords

Adalimumab Adjunctive therapy Biologic therapy Calcipotriene/betamethasone dipropionate (Cal/BD)Cost analysis Etanercept Observational study Plaque psoriasis Topical therapy

Licence

Exports